Press Releases 2012

Press Releases 2012

[Geneva, Switzerland – 30 January 2012]
Filling R&D Gaps Key to Succeeding in NTD Control and Elimination Goals by 2020
On the occasion of today’s high-level event in London, ‘Uniting to Combat Neglected Tropical Diseases,’ organized in support of the new World Health Organization (WHO) Neglected Tropical Disease (NTD) 2020 Roadmap, the Drugs for Neglected Diseases initiative (DNDi) welcomes the commitments from various partners and emphasizes that filling the major gaps in research and development (R&D) to develop new treatment and diagnostic tools is key to effectively support elimination or control of targeted NTDs by 2020. [Deutsch] [Español] [Português] [Japanese]

More

Press Releases 2012

[Geneva, Switzerland – 30 January 2012]
DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
The Drugs for Neglected Diseases initiative (DNDi) and Abbott have signed a four-year joint research and non-exclusive licensing agreement to undertake research on new treatments for several of the world's most neglected tropical diseases, including Chagas disease, helminth infections, leishmaniasis and sleeping sickness. Through this collaboration, DNDi and Abbott scientists will focus initial efforts on discovering and advancing novel antimicrobial agents with activity against these neglected diseases.

More

Press Releases 2012

[Geneva, Switzerland – 23 January 2012]
Germany’s Federal Ministry of Education and Research Grants EUR 8 Million to DNDi for the Development of New Treatments for Neglected Tropical Diseases
The Federal Ministry of Education and Research of Germany (BMBF) has granted EUR 8 Million  to the Drugs for Neglected Diseases initiative (DNDi) to develop innovative treatments for neglected tropical diseases. The grant will be disbursed over the period of 2011-2015 and is part of a larger funding programme of EUR 20 million allocated by the BMBF to three product development partnerships (PDPs)*. [Deutsch]

More